Asia-Pacific Market Growth Potential Offset by Domestic

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Asia-Pacific Market Growth Potential Offset by Domestic Regulations And Cultural Attitudes in Dental Biologics Markets

VANCOUVER, BC, April 30, 2015 (GLOBE NEWSWIRE) -- via PRWEB - According to a recent report by iData Research ( http://www.idataresearch.com ), the majority of the Asia-Pacific dental bone graft substitute (DBGS) and barrier membrane markets are set to grow significantly. China is expected to demonstrate the highest levels of growth, while Japan will exhibit the lowest. The significant surge of dental implant procedure numbers is set to generate major market value growth. The rise of the implant market in all four countries is set to continue to fuel growth for the DBGS and dental barrier membrane markets in the overall region.

"Domestic regulations on medical devices in the Asia-Pacific region have largely limited growth. However, growing consumer awareness, and research and development efforts are driving the market," explains Dr. Kamran Zamanian, CEO of iData. "Acceptance and availability of xenograft and allograft materials are expected to further fuel market growth."

The South Korean market for DBGS and barrier membranes is the most highly developed relative to the other countries in the Asia-Pacific region. As a result of the high market penetration of both dental implants and related regenerative/biomaterial products, growth is expected to be relatively modest in comparison to other Asia-Pacific countries.

The Australian market is more moderately developed as a result of consumer awareness levels and a higher GDP per capita. Approvals of allograft materials and the recently established subsidiary by Geistlich are set to generate DBGS and dental barrier membrane market growth in Australia.

Leading Competitors

Geistlich is the clear market leader of the DBGS and barrier membrane markets in the Asia-Pacific region with a market share of almost 50% due to its presence in all four countries. Geistlich is the only company that possesses licensed approval for the distribution of its products in all four of the regions in Asia-Pacific.

Domestic market leaders vary greatly from country to country due to varying regulations in each country.

Other notable competitors in the Asia-Pacific markets for dental bone graft substitutes and barrier membranes include Genoss, Olympus Terumo Biomaterials, HOYA Techsurgical, Hans Biomed, Shanxi OsteoRad, Zimmer Dental, among others.

For Further Information

More on the DBGS market in the Asia-Pacific region can be found in the report series published by iData entitled Asia-Pacific Markets for Dental Bone Graft Substitutes and Barrier Membranes . This report covers Japan, South Korea, Australia, and China, and includes market segment for allografts, xenografts, synthetics, resorbable barrier membranes, and non-resobable barrier membranes.

The full iData series on the market for DBGS and barrier membranes covers the U.S., Brazil, Argentina, Mexico, China, Japan, South Korea, Australia, India, and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment.

Register online or email us at info(at)idataresearch(dot)net for an Asia-Pacific Markets for Dental Bone Graft Substitutes and Barrier Membranes report brochure and synopsis.

About Procedure Tracker

Procedure number data is available from iData's Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by country, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About iData Research

iData Research ( http://www.idataresearch.com ) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/05/prweb12690635.htm

iData Research Marvin Cidamon +1 (604) 266-6933 Ext: 205

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insight into Northern 3 VCT PLC's Voting Rights Structure

Updated Category News Views 135

Understanding Voting Rights at Northern 3 VCT PLC On June 30, 2025, Northern 3 VCT PLC (LSE: NTN) provided important information regarding its voting rights. This transparency aligns with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, which are essential for maintaining investor trust and market integrity. Current Capital Structure The...

Continue Reading
BAWAG Group Reports Strong Q3, Exceeding Performance Goals

Updated Category News Views 264

BAWAG Group's Impressive Third Quarter Financial Performance Recently, BAWAG Group announced remarkable financial results for the third quarter of 2025. The company achieved a significant net profit of €219 million, translating to earnings per share of €2.77 and a return on tangible common equity (RoTCE) of 27.8%. This robust performance highlights the solid operating...

Continue Reading
Jet.AI Partners with Consensus Core for AI Data Center Venture

Updated Category News Views 145

Jet.AI and Consensus Core Unveil Ambitious AI Data Center Plans In an exciting development for the artificial intelligence landscape, Jet.AI Inc. (Nasdaq: JTAI) has taken a significant step forward by signing a Letter of Intent with Consensus Core Technologies Inc., a leader in high-performance GPU infrastructure. This partnership aims to launch a formidable joint venture...

Continue Reading
edatanetworks Secures Patent for Innovative Cause Marketing Tool

Updated Category News Views 161

edata networks Inc. scored big back in early 2024 when they got the thumbs-up from the USPTO for patent 18/084,836. Traders who caught that buzz saw an opportunity brewing, especially with how it aimed to shake up cause marketing. That’s no small feat; we’re talking about a company looking to automate donations tied to customer transactions—a direct shot at...

Continue Reading
American Attitudes Towards Bitcoin: A Deep Dive into Skepticism

Updated Category News Views 142

Understanding American Perspectives on Bitcoin In recent times, Bitcoin has made headlines by reaching impressive all-time highs, yet a significant portion of the American public remains cautious. A recent Gallup poll highlights that a majority of Americans perceive cryptocurrencies as a gamble beyond their financial reach. This reality reveals intriguing insights into...

Continue Reading